- Pegvisomant
Drugbox
IUPAC_name =
CAS_number =
ATC_prefix = H01
ATC_suffix = AX01
PubChem =
DrugBank =
chemical_formula =
molecular_weight =
bioavailability =
protein_bound =
metabolism =
elimination_half-life =
excretion =
pregnancy_AU =
pregnancy_US =
pregnancy_category=
legal_AU =
legal_CA =
legal_UK =
legal_US =
legal_status =
routes_of_administration =Pegvisomant is a
growth hormone receptor antagonist used in the treatment ofacromegaly .cite journal | last=Schreiber | first=I | coauthors= Buchfelder M, Droste M et al. | title=Treatment of acromegaly with the GH receptor antagonist pegvisomant in clinical practice: safety and efficacy evaluation from the German Pegvisomant Observational Study | journal=European Journal of Endocrinology | volume=156 | issue=1 | pages=75–82 | date=January 2007 | url=http://www.eje-online.org/cgi/content/full/156/1/75?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&author1=Schreiber&andorexactfulltext=and&searchid=1&FIRSTINDEX=0&sortspec=relevance&volume=156&resourcetype=HWCIT | pmid=17218728 | doi=10.1530/eje.1.02312 ]References
Wikimedia Foundation. 2010.
